Single chapter.

Articles in this section · 11

L2151-1L2151-2L2151-3L2151-4L2151-5L2151-6L2151-7L2151-8L2151-9L2151-10L2151-11

Article L2151-6

French Public Health CodeIn force
Ask for lawyer reviewed or certified translation

Updated 7 Nov 2023

I.- Embryonic stem cell research protocols are subject to declaration to the Agence de la biomédecine prior to their implementation.

II.-Embryonic stem cell research may only be conducted using:

1° Embryonic stem cells derived from embryos, as part of an embryo research protocol authorised in application of Article L. 2151-5;

2° Embryonic stem cells which have been the subject of an import authorisation in application of Article L. 2151-8.

Gametes obtained from embryonic stem cells may in no way be used to fertilise another gamete, obtained by the same process or collected by donation, in order to conceive an embryo.

III. -The Director General of the Agence de la biomédecine shall object, within a period set by regulation, to the implementation of the research protocol mentioned in I of this article if the fundamental or applied research does not have a medical purpose or is not intended to improve knowledge of human biology, if the scientific relevance of the research has not been established, if the protocol or the conditions under which it is carried out do not comply with the fundamental principles set out in articles 16 to 16-8 of the Civil Code or the ethical principles set out in this Title and in Title I of Book II of Part One of this Code, or if the authorisations referred to in II of this article have not been obtained.

Where the purpose of the protocol referred to in I is to differentiate embryonic stem cells into gametes, to obtain models of embryonic development in vitro or to insert these cells into an animal embryo with the aim of transferring it to a female, any objection made pursuant to the first paragraph of this III shall be made after obtaining the public opinion of the Agency's Steering Committee.

In the absence of any objection from the Director General of the Agency, the research protocol may begin on expiry of the period referred to in the same first paragraph.

IV.The Director General of the Agence de la biomédecine may at any time suspend or prohibit, after receiving the public opinion of the Agency's Orientation Board, the research mentioned in I which no longer meets the requirements mentioned in III.

Mariela Petrova

Need help applying this article to your situation?

A registered French Lawyer explains what applies to your business — in English, fixed fee.

within 48h

Fixed Fee

Talk to a lawyer
Previous articleArticle L2151-5Next articleArticle L2151-7
Common Questions

Working with a corporate lawyer in France — Q&A

Any time a strategic decision changes how the company is owned, governed or contractually bound — incorporation, fundraising, M&A, restructuring, shareholder agreements, or major commercial contracts. Earlier engagement always costs less than later remediation.

A notary (notaire) is a public officer who authenticates specific deeds (mainly real-estate transfers and certain family-law acts). A corporate lawyer (avocat) advises on strategy, negotiates and drafts company documents, and represents you in disputes. The two roles complement rather than overlap.

Yes — most of our clients are foreign suppliers, investors or holding entities. We bridge the gap between French law and your home jurisdiction's expectations and deliver everything bilingually.

The SAS (Société par Actions Simplifiée) is the default choice for most international structures: flexible governance, single shareholder allowed, no minimum capital, and works cleanly with foreign holding entities. We assess SARL, SA, SCI on the merits when the situation calls for it.

Yes — communications with a French avocat are protected by the secret professionnel (Article 66-5 of the Law of 31 December 1971). This protection is broader than the common-law attorney-client privilege and applies to written and oral exchanges.

We work on fixed fees for clearly scoped engagements (incorporation, contract drafting, audits) and on monthly retainers for ongoing advisory. Hourly billing is the exception, not the default. You always know the cost before work starts.

Typical timeline is 2–3 weeks from KYC kick-off to RCS registration, assuming standard documentation. Holding-company structures, foreign-shareholder identification or in-kind contributions can extend this — we flag the gating items at the first meeting.

Absolutely. We routinely coordinate with your in-house counsel, expert-comptable or notaire — pragmatic collaboration is the norm, not the exception. We send them everything they need to do their part without duplicating work.

Mariela Petrova

Mariela Petrova

Avocate au Barreau de Paris

Toque #C2396

15+ Years In Corporate Practice

English · French · Russian

Ready When You Are

Talk To A Corporate
Lawyer In France.

A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.

Talk To A Corporate Lawyer+33 1 84 88 31 00
First EngagementFixed Fee

Talk to a French lawyer.

Reply within 24 hours.

Communications protected by professional secrecy — secret professionnel de l'avocat, Article 66-5 of the Law of 31 December 1971.

Continue Reading

Related corporate services in France

01 / Setup

Setting up a French company

Choose between SAS, SARL, SA or SCI — and structure your first French entity around how you actually plan to operate.

Read More
02 / Operating

French commercial contracts

Distribution, agency, supply, services and IP licences — drafted around the protections French law actually gives.

Read More
03 / Disputes

Business disputes & litigation

Shareholder conflicts, commercial breaches and pre-litigation strategy — handled by the same team that knows the file.

Read More